Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Dec 29, 2023
DEFA14A Dec 19, 2023
8-K Dec 19, 2023
RW Nov 30, 2023
8-K Nov 29, 2023
EFFECT Nov 21, 2023
CORRESP Nov 20, 2023
S-1/A Nov 17, 2023
8-K Nov 17, 2023
UPLOAD Nov 17, 2023
DEFA14A Nov 13, 2023
DEF 14A Nov 13, 2023
S-1 Nov 9, 2023
8-K Nov 9, 2023
10-Q Nov 9, 2023
PRE 14A Oct 30, 2023
8-K Oct 24, 2023
S-8 Oct 20, 2023
8-K Aug 28, 2023
8-K Aug 11, 2023
10-Q Aug 11, 2023
SC 13D/A Jul 18, 2023
DEFA14A Jul 14, 2023
DEF 14A Jul 14, 2023
8-K Jun 14, 2023
← Newer Page 6 of 22 · 546 filings Older →